Question 1

What specific medications were tested in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 clinical trial (NCT00047606). Contact the study team or your healthcare provider for specific answers.

Question 2

How do these medications compare to what I am currently using?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 clinical trial (NCT00047606). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of from these treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 clinical trial (NCT00047606). Contact the study team or your healthcare provider for specific answers.

Question 4

How long would I need to participate in a similar study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 clinical trial (NCT00047606). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 clinical trial (NCT00047606). Contact the study team or your healthcare provider for specific answers.

What this study is about